Dalhousie’s Student Leadership Academy is excited to introduce the newest High-Performance Leadership cohort. This group of students will bring big ideas, deep community involvement, and an impressive range of leadership experience to the year ahead.

Held on March 26 in the Sir Charles Tupper Medical Building, Community Engagement Day brought together students, faculty, staff, and community partners, all united by a shared commitment to improving health equity through collaboration.

Four Dalhousie researchers are set to embark on the next chapter of their scholarly careers with strong momentum behind them as Killam Memorial Chairs. 

Across Atlantic Canada, physicians are seeing more patients diagnosed with lung cancer who have never smoked. It’s a shift that challenges one of the most established narratives in public health. For decades, lung cancer has been closely tied to tobacco. That connection remains. But it no longer explains everything.

Dalhousie researchers, Drs. Jean Marshall and Michael Bezuhly, along with their research team, are uncovering an exciting and unexpected biological pathway that may lead to entirely new treatments for fibrosis and abnormal scarring, conditions that affect millions of people worldwide.

As of January 2025, an estimated 771,939 people in Canada are living with dementia, and more than 414 Canadians develop the condition every day. Within the decade, nearly one million families across the country will be living with the impacts of Alzheimer’s disease and related dementias—a number that continues to climb as the population ages.

The moment a medical student begins asking deeper questions, medicine moves forward. Why does one patient respond to treatment while another does not? How can disease be detected earlier? How can care be delivered more effectively in rural communities?

When Dr. Karen Lithgow, assistant professor in the Department of Microbiology and Immunology at Dalhousie, first arrived at Dalhousie University last spring, she brought with her a research focus that is both scientifically complex and historically overlooked: the vaginal microbiome.

At Dalhousie, Multiple Sclerosis (MS) research begins with a simple question: What does it take for someone with MS to live the best life possible?

Led by Dalhousie University, BioLabs East will establish a new Good Manufacturing Practice (GMP) facility in Nova Scotia, giving academic, health care, and industry partners the specialized infrastructure needed to accelerate research toward clinical trials.